WILLIAM A. SODEMAN, M.D., F.A.C.P.; A. A. DOERNER, M.D., F.A.C.P.; E. M. GORDON, M.D., F.A.C.P.; C. M. GILLIKIN, M.D.
The introduction by Conan1 of chloroquine as an antiamebic agent and his demonstration of its usefulness in hepatic amebiasis established the efficacy of a relatively nontoxic drug in amebic infections of the liver. These observations were soon confirmed by Shookhoff2 in 12 cases, by Sodeman3 in two, and by others.4, 5, 6
The present report concerns our experiences with the two patients of Sodeman referred to by personal communication by Conan,1 and with five additional patients. In all, we are reporting seven instances of hepatic amebiasis in which chloroquine was used. These case reports, aside from further confirming the effect
SODEMAN WA, DOERNER AA, GORDON EM, GILLIKIN CM. CHLOROQUINE IN HEPATIC AMEBIASIS1. Ann Intern Med. ;35:331–341. doi: 10.7326/0003-4819-35-2-331
Download citation file:
Published: Ann Intern Med. 1951;35(2):331-341.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use